Screening for the Biggest Cancer Killer: Beating Lung Cancer Through Screening Guidelines?
Denis Horgan, PhD, LLM, MSc, BCLMany of Europe’s achievements and commitments have been exemplary in the development of health-related science, technology, and regulation, and the European Union (EU) is on the brink of providing further […] Read more
Management of Breathlessness in Lung Cancer Post-Surgery: An Interview With U.S. and U.K. Nurses
Samantha Jayne Byam+more
Breathlessness or shortness of breath (SOB) can be a short-term or long-term side effect after surgery, particularly lobectomy, for patients with NSCLC. There is good evidence now to support use […] Read more
On May 28, the US Food and Drug Administration (FDA) granted accelerated approval of sotorasib for patients with KRAS G12C-mutated NSCLC who have received at least one prior line of […] Read more
Biomarkers May Illuminate the Path Forward for PARP Inhibitors in SCLC
Marcelo V. Negrao+more
Despite U.S. Food and Drug Administration (FDA) approvals for the addition of anti–programmed death-ligand 1 (PD-L1) therapies to a first-line combination of etoposide plus a platinum-based agent for extensive-stage small […] Read more
October 2, 2020, saw the first U.S. Food and Drug Administration approval of a drug combination for malignant pleural mesothelioma in 16 years, since the combination cisplatin and pemetrexed was […] Read more
Anne Katz, PhD, RN, FAAN, is a certified sexuality counselor and clinical nurse specialist at Cancer Care Manitoba, Winnipeg, Canada, and the author of multiple books on cancer survivorship. In the following article, Dr. Katz discusses lung cancer survivorship challenges as well as considerations that providers should take... Read more
Walter J. “Wally” Curran, Jr., MD, the first radiation oncologist to serve as director of a National Cancer Institute-designated comprehensive cancer center, stepped down from that role at Emory University’s […] Read more
Anne-Marie Dingemans, MD, PhD, was installed in January 2021 as chair of the European Organisation for Research and Treatment of Cancer Lung Cancer Group, filling a role previously held by […] Read more
Marina Chiara Garassino, MD, stepped into a role as professor of medicine in the Section of Hematology/Oncology at the University of Chicago Department of Medicine in March 2021, making a […] Read more
Leveraging Lung Cancer Screening Scans to Detect Early Interstitial and Obstructive Lung Disease
Kara Nyberg, PhDCT screening for lung cancer can reveal subtle early signs of disease in the lungs that extend beyond potential malignancy. As reviewed by Bram van Ginneken, PhD, of the Radboud […] Read more